11:15:26 EDT Fri 19 Aug 2022
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Tilray Brands Inc
Symbol TLRY
Shares Issued 446,156,841
Close 2022-06-21 C$ 4.25
Recent Sedar Documents

Tilray hosts Luxembourg delegation at Portugal campus

2022-06-22 11:51 ET - News Release

Mr. Sascha Mielcarek reports

TILRAY MEDICAL WELCOMES GOVERNMENT OF LUXEMBOURG DELEGATION VISIT TO EUROPEAN CAMPUS IN PORTUGAL

Tilray Brands Inc. is welcoming the Luxembourg Ministry of Health delegation to the company's European campus and facility located in Cantanhede, Portugal. Tilray's EU-GMP-certified medical cannabis cultivation and manufacturing facility in Portugal provides patients in Luxembourg and across Europe, where permitted by law, with safe and reliable access to high-quality medical cannabis.

The visit was organized to give the Luxembourg Delegation a firsthand view of Tilray's EU-GMP operations in Portugal, the premiere medical cannabis site in Europe. The delegation included:

Paulette Lenert, Deputy Prime Minister and Minister of Health of Luxembourg

H. E. Conrad Bruch, Ambassador of Luxembourg to Portugal

Alain Origer, National Drugs Coordinator

Laura Valli, International Affairs Coordinator

Bob Lessel, Social Health Department

Sven Back, Department of narcotics and medicinal cannabis

Sascha Mielcarek, Tilray's Managing Director in Europe, said, "We are honored to host the Luxembourg Ministry of Health Delegation at our state-of-the-art cannabis facility in Cantanhede, Portugal. Demand for cannabis legalization in Europe is growing rapidly and we are incredibly proud to service the patients in Luxembourg and around the world with the high-quality medical cannabis products they rely on and in the formats they prefer."

Tilray has a pioneering track record as a company committed to producing the highest-quality cannabis products available to consumers and patients in need around the world and was the first to successfully export medical cannabis from North America and import medical cannabis products into the EU in 2016.

About Tilray Medical

Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, and Symbios. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments, in 20 countries and across five continents. For more information on Tilray Medical, visit Tilray Medical Canada, Tilray Medical Australia, Tilray Medical Australia-New Zealand, Tilray Medical Europe

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better - one person at a time. Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live their very best life and providing access to products that meet the needs of their mind, body, and soul while invoking wellbeing. Patients and consumers trust Tilray Brands to deliver a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray's unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

We seek Safe Harbor.

© 2022 Canjex Publishing Ltd. All rights reserved.